AstraZeneca PLC (AZN) vs QUALCOMM Incorporated (QCOM)
AZN leads on 10 of 16 compared metrics, though QCOM is the cheaper stock.
A side-by-side comparison of AstraZeneca PLC and QUALCOMM Incorporated across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of June 15, 2026. The ● marks the stronger figure on each row (cheaper multiple, higher margin/return).
Total return — AZN vs QCOM
growth of $100 · last 30yAZN +732.9%QCOM +7150.7%QCOM compounded faster
Log scale — wide-divergence pair
AZN QCOM
AZN vs QCOM: by the numbers
- •AZN is the larger company ($277.22B vs $223.15B market cap).
- •QCOM trades at the lower earnings multiple (22.72 vs 26.92 P/E).
- •QCOM converts more revenue to profit (22.31% vs 17.19% net margin).
- •AZN grew revenue faster over the past five years (16.99% vs 8.63% CAGR).
- •AZN pays the higher dividend yield (1.79% vs 1.70%).
Which is better, AZN or QCOM?
Metric tally: AZN 10 · QCOM 6It depends on what you're optimizing for:
ValueQCOM(lower P/E)
GrowthAZN(faster 5Y revenue CAGR)
IncomeAZN(higher dividend yield)
Metrics side by side
Valuation
| Metric | AZN | QCOM |
|---|---|---|
| P/E ratio | 26.92 | 22.72● |
| Forward P/E | 15.33● | 19.72 |
| P/S ratio | 4.62● | 5.10 |
| P/B ratio | 5.90● | 8.32 |
| PEG ratio | 0.14● | 3.96 |
| EV / EBITDA | 14.92● | 16.71 |
| FCF yield | 2.89% | 5.51%● |
Profitability
| Metric | AZN | QCOM |
|---|---|---|
| Gross margin | 81.68%● | 54.80% |
| Operating margin | 23.69% | 25.52%● |
| Net margin | 17.19% | 22.31%● |
| ROE | 21.95% | 36.38%● |
| ROIC | 13.03% | 13.15% |
Dividends
| Metric | AZN | QCOM |
|---|---|---|
| Dividend yield | 1.79%● | 1.70% |
| Payout ratio | 48.48% | 70.95% |
Growth (annualized)
| Metric | AZN | QCOM |
|---|---|---|
| Revenue CAGR (5Y) | 16.99%● | 8.63% |
| EPS CAGR (5Y) | 22.02%● | 5.74% |
| FCF CAGR (5Y) | 15.68%● | 9.39% |
| Total return CAGR (5Y) | 11.03% | 11.87%● |
Frequently asked
- Which is better, AZN or QCOM?
- It depends on your goal. value: QCOM (lower P/E); growth: AZN (faster 5Y revenue CAGR); income: AZN (higher dividend yield). Across all compared metrics, AZN leads 10 to 6.
- Is AZN or QCOM cheaper?
- On trailing earnings, QCOM is cheaper: AZN trades at a 26.92 P/E and QCOM at 22.72.
- Which has grown faster, AZN or QCOM?
- Over the past five years, AZN grew revenue faster — AZN at a 16.99% CAGR versus QCOM at 8.63%.
- Does AZN or QCOM pay a bigger dividend?
- AZN yields 1.79% and QCOM yields 1.70% based on trailing dividends and the latest price.
- Is AZN or QCOM more profitable?
- QCOM runs the higher net margin — AZN at 17.19% versus QCOM at 22.31%.
- Which has been the better investment, AZN or QCOM?
- Over the past 10-year, QCOM delivered the higher annualized total return — AZN at 15.77% versus QCOM at 17.83%. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
AstraZeneca P/E ratioQUALCOMM P/E ratioAstraZeneca dividend yieldQUALCOMM dividend yieldAstraZeneca ROEQUALCOMM ROEAstraZeneca operating marginQUALCOMM operating marginAstraZeneca revenue growthQUALCOMM revenue growthAstraZeneca free cash flowQUALCOMM free cash flow
AstraZeneca & QUALCOMM appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified June 15, 2026.